Gan & Lee Pharmaceuticals.

¥71.38As of Sun 8 Nov 2026, 12:00 UTC
SSE:603087Healthcare
Country China
PE (Fwd) •••
TSR 6Y CAGR 0.94%
Div yield 1.40%
ROE 10.17%
Medical Instruments & Supplies
Beta (5Y) 0.34
PE TTM 35.69
TSR TTM 7.02%
Mkt cap ¥42.49B
ROIC 11.03%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥89
25.14%
(21.32%)
Hold 4|0|1|3|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
1.05
1.13
1.25
1.37
26.92%
31.86%
39.56%
44.85%
Revenue¥B
3.834
4.051
4.284
4.264
10.49%
16.83%
21.13%
14.56%
Peers (US$6.370B)
Cap (US$)
PE
4.082B
27.61x
3.535B
30.34x
6.359B
24.20x
Capital
TTM
5Y
10Y
Leveragex
1.372
0.011
0.011
EBIT/Intx
0.222
0.273
0.261
Own earn%
(37.22)
25.34
35.52
Sh yield%
22.21
10.67
11.37
Owners
Insiders/Inst%
9.89
62.79
Short interest%
5.53
SBC / revenue%
1.16
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
12–19
$1 testx
−0.2
Incr. ROIC%
20